JCI Insight 5(6):e133429 Drucker DJ (2018) Mechanisms of action and therapeutic application of glucagon-like peptide-1
For treatment to work, therefore, root causes must be identified, then addressed, for each person
Kandiah N, Ong PA, Yuda T, Ng L, Mamun K, Merchant RA, Chen C, Dominguez J, Marasigan S, Ampil E et al (2019) Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: expert consensus on the use of Ginkgo biloba extract, EGb 761
GLP-1 receptors are found in the pancreas, gut, and brain
Retatrutide is an investigational triple incretin receptor agonist targeting GLP-1, GIP, and glucagon receptors to reduce appetite and body weight, while tesamorelin is a growth hormone-releasing hormone analogue that stimulates pituitary GH release to reduce visceral fat, primarily in HIV-positive patients with lipodystrophy